1. Home
  2. GCTK vs PLRZ Comparison

GCTK vs PLRZ Comparison

Compare GCTK & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • PLRZ
  • Stock Information
  • Founded
  • GCTK 2001
  • PLRZ 2005
  • Country
  • GCTK United States
  • PLRZ Israel
  • Employees
  • GCTK N/A
  • PLRZ N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • PLRZ
  • Sector
  • GCTK Health Care
  • PLRZ
  • Exchange
  • GCTK Nasdaq
  • PLRZ NYSE
  • Market Cap
  • GCTK 5.1M
  • PLRZ 5.9M
  • IPO Year
  • GCTK N/A
  • PLRZ 2024
  • Fundamental
  • Price
  • GCTK $0.37
  • PLRZ $1.04
  • Analyst Decision
  • GCTK
  • PLRZ
  • Analyst Count
  • GCTK 0
  • PLRZ 0
  • Target Price
  • GCTK N/A
  • PLRZ N/A
  • AVG Volume (30 Days)
  • GCTK 4.1M
  • PLRZ 136.1K
  • Earning Date
  • GCTK 03-27-2025
  • PLRZ 02-15-2025
  • Dividend Yield
  • GCTK N/A
  • PLRZ N/A
  • EPS Growth
  • GCTK N/A
  • PLRZ N/A
  • EPS
  • GCTK N/A
  • PLRZ N/A
  • Revenue
  • GCTK N/A
  • PLRZ N/A
  • Revenue This Year
  • GCTK N/A
  • PLRZ N/A
  • Revenue Next Year
  • GCTK N/A
  • PLRZ N/A
  • P/E Ratio
  • GCTK N/A
  • PLRZ N/A
  • Revenue Growth
  • GCTK N/A
  • PLRZ N/A
  • 52 Week Low
  • GCTK $0.36
  • PLRZ $0.77
  • 52 Week High
  • GCTK $99.00
  • PLRZ $4.80
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 26.08
  • PLRZ N/A
  • Support Level
  • GCTK $0.49
  • PLRZ N/A
  • Resistance Level
  • GCTK $0.68
  • PLRZ N/A
  • Average True Range (ATR)
  • GCTK 0.20
  • PLRZ 0.00
  • MACD
  • GCTK 0.17
  • PLRZ 0.00
  • Stochastic Oscillator
  • GCTK 0.71
  • PLRZ 0.00

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About PLRZ POLYRIZON LTD

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Share on Social Networks: